The newly launched biotech is equipped with rights to a trio of weight loss medicines licensed from China-based Sciwind ...

Maridebart cafraglutide, a novel injectable GIP receptor antagonist/GLP-1 receptor agonist, reduced body weight by ...

Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an ...

Obesity is a severe public health problem, contributing significantly to the global non-communicable disease burden, ...

Pfizer is advancing on a broad front in its attempt to catch up with Novo Nordisk and Eli Lilly in the obesity drug category ... Reimagining What's Possibl In a new white paper from the ...

Researchers at UT Southwestern Medical Center discovered that genetically modifying fat cells in obese mice to produce higher ...